Modifiying genes in hereditary diseases;Les genes modificateurs dans les maladies hereditaires

Medecine/Sciences

Volumn 16, Issue 4, 2000, Pages

  Feingold, Josué ^a,b  

^a UNIVERSITÉ PARIS DESCARTES   (France)

^b HÔPITAL NECKER ENFANTS MALADES   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ALLELE; DNA MODIFICATION; ENVIRONMENTAL FACTOR; FAMILIAL DISEASE; GENETIC DISORDER; GENETIC EPIDEMIOLOGY; HUMAN; NONHUMAN; ONSET AGE; PHENOTYPE; SHORT SURVEY; SIBLING;

ANIMALIA;

EID: 0034010638     PISSN: 07670974     EISSN: None     Source Type: Journal    
DOI: 10.4267/10608/1699     Document Type: Short Survey

References (28)

1. Romeo G, McKusick VA. Phenotypic diversity, allelic series and modifier genes. Nat Genet 1994; 7: 451-3.
2. Estivill X. Complexity in a monogenic disease. Nat Genet 1996; 12: 348-50.
3. Summers KM. Relationship between genotype and phenotype in monogenic diseases: relevance to polygenic diseases. Hum Mut 1996; 7: 283-93.
4. Wolf U. Identical mutations and phenotypic variation. Hum Genet 1997; 100: 305-21.
5. Houlston RS, Tomlinson IPM. Modifier genes in humans: strategies for identification. Eur J Hum Genet 1998; 6: 80-8.
6. Labie D, Elion J. Modulation polygénique des maladies monogéniques: l'exemple de la drépanocytose. Med Sci 1996; 12: 341-9.
7. Dietrich WF, Lander ES, Smith JS, et al. Genetic identification of Mom-1, a major modifier locus affecting Min-induced intestinal neoplasia in the mouse. Cell 1993; 75: 631-9.
8. Cormier RT, Hong KH, Halberg RB, et al. Secretory phospholipase P1a2g2a confors resistance to intestinal tumor genesis. Nat Genet 1997; 17: 88-91.
9. Fisher RA. The evolution of dominance in certain polymorphic species. Am Nat 1930; 64: 385-406.
10. Souied EH, Ducroq D, Gerger S, et al. Age-related degeneration in grand parents of patients with Stargardt disease: genetic study. Am J Ophthalmol 1999; 128: 173-8.
11. Haldane JBS. The relative importance of principal and modifying genes in determining some human diseases. J Genet 1941; 41: 149-57.
12. Renwick JH. Nail-patella syndrome: evidence for modification by alleles at the main locus. Ann Hum Genet 1956; 21: 159-69.
13. Dreyer SD, Zhou G, Baldini A, et al. Mutation in LMX1B cause abnormal skeletal patterning and renal dysplasia. Nat Genet 1998; 19: 47-50.
14. McGee TL, Devoto M, Ott J, et al. Evidence that the penetrance of mutations at the RP11 locus causing dominant retinitis pigmentosa is influenced by a gene linked to the homologous RPM allele. Am J Hum Genet 1997; 61: 1059-66.
15. Gouya L, Deybach JC, Lamoril J, et al. Modulation of the phenotype in dominant erythropoietic protoporphyria by a low expression of the normal ferrochelatase allele. Am J Hum Genet 1996; 58: 292-9.
16. 1c1s, un allèle tranquille mais dangereux du gène α-spectrine érythroïde. Med Sci 1995; 11: 752-4.
17. Goldfarb LG, Petersen RB, Tabaton M, et al. Fatal familial insomnia and familial Creutzfeldt-Jakob disease: disease phenotype determined by a DNA polymorphism. Science 1992; 258: 806-8.
18. Laham T, Grabowski GA, Bimal DM, et al. Complex allele of the acid β-glucosidase gene in Gaucher disease. Am J Hum Genet 1990; 47: 79-86.
19. Kiesewetter S, Macek M, Davis C, et al. A mutation in CFTR produces different phenotypes depending on chromosomal background. Nat Genet 1993; 5: 274-8.
20. Cuppens H, Lin W, Jaspers M, et al. Polyvariant mutant cystic fibrosis transmembrane conductance regulator genes. J Clin Invest 1998; 101: 4787-96.
21. Monplaisir N, Merault G, Poyart C, et al. Haemoglobin S Antilles: a variant with lower solubility than haemoglobin S and producing sickle cell diseases heterozygotes. Proc Natl Acad Sci USA 1986; 83: 9363-7.
22. Langdown JV, Williamson D, Knight CB, et al. A new doubly substituted sickling haemoglobin: HBS-Oman. Br J Haematol 1989; 71: 443-4.
23. Lefèbvre S, Burglen L, Munnich A, Melki J. The role of the SMN gene in proximal muscular atrophy. Hum Mol Genet 1998; 7: 1531-6.
24. Tesson F, Dufour C, Johanna C, et al. The influence of angiotensin I converting enzyme genotype in familial hypertrophic cardiomyopathy varies with the disease gene mutation. J Mol Cell Cardiol 1997; 29: 831-8.
25. Aams RN, Kutlar A, McKie V, et al. Alpha thalassemia and stroke risk in sickle cell anemia. Am J Hematol 1994; 45: 279-82.
26. Craig JE, Rochette J, Fisher CA, et al. Dissecting the loci controlling fetal haemoglobin production on chromosome 11p and 6q by the regressive approach. Nat Genet 1996; 12: 58-64.
27. Rozmahel R, Wilschanski M, Matin A, et al. Modulation of disease severity in cystic fibrosis transmembrane conductance regulator deficient mice by a secondary factor. Nat Genet 1996; 12: 280-7.
28. Zielenski M, Corey D, Markiewicz I, et al. Mapping of cystic fibrosis modifier (CFM) loci in the human genome. Am J Hum Genet 1998; 63: A54.